Benzamide, an inhibitor of poly(ADP-ribose) polymerase, attenuates methamphetamine-induced dopamine neurotoxicity in the C57B1/6N mouse

Brain Research

Volumn 735, Issue 2, 1996, Pages 343-348

  Cosi, Cristina ^a   Chopin, Philippe ^a   Marien, Marc ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Benzamide; C57B1 6N mouse; Methamphetamine; Neuroprotection; Neurotoxicity; Poly(ADP ribose) polymerase; Striatal dopamine

Indexed keywords

BENZAMIDE; CHLORPROMAZINE; HALOPERIDOL; METHAMPHETAMINE; NEUROPROTECTIVE AGENT; NOMIFENSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0030574060     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00918-3     Document Type: Article

References (28)

1. [1] Ali, S.F., Newport, G.D., Holson, R.R., Slikker, W. Jr. and Bowyer, J.F., Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice, Brain Res., 658 (1994) 33-38.
2. [2] Althaus, F.R. and Richer, C., ADP-Ribosylation of Proteins: Enzymology and Biochemical Significance. Molecular Biology, Biochemistry and Biophysics, Vol. 37, Springer-Verlag, New York, 1987, 237 pp.
3. [3] Banasik, M., Komura, H., Shimoyama, M. and Ueda, K., Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribose) transferase, J. Biol. Chem., 267 (1992) 1569-1575.
4. [4] Cadet, J.L., Sheng, P., Ali, S., Rothman, R., Carlson, E. and Epstein, C., Attenuation of methamphetamine-induced neurotoxicity in copper/zinc Superoxide dismutase transgenic mice, J. Neurochem., 62 (1994) 380-383.
5. [5] Chan, P., Di Monte, D.A., Luo, J.J., DeLanney, L.E., Irwin, I. and Langston, J.W., Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic toxicity, J. Neurochem., 62 (1994) 2484-2487.
6. [6] Cosi, C., Suzuki, H., Milani, D., Facci, L., Menegazzi, M., Vantini, G., Kanai, Y. and Skaper, S.D., Poly(ADP-ribose)polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells, J. Neurosci. Res., 39 (1994) 38-46.
7. [7] Cosi, C., Suzuki, H., Facci, L., Milani, D. and Skaper, S.D., Poly(ADP-ribose)polymerase: an early marker of glutamate mediated neuronal death, Soc. Neurosci. Abstr., 18 (1992) 46.
8. [8] Cosi, C., Colpaert, F., Koek, W., Degryse, A. and Marien, M., Poly(ADP-ribose)polymerase inhibitors protect against MPTP-induced depeltions of striatal dopamine and cortical noradrenaline in C57B1/6 mice, Brain Res., 729 (1996) 264-269.
9. [9] De Vito, M.J. and Wagner, G.C., Methamphetamine-induced neuronal damage: a possible role for free radicals, Neuropharmacology, 8 (1989) 1145-1150.
10. [10] Fomai, F., Bassi, L., Torracca, M.T., Scalori, V. and Corsini, G.U., Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice, Eur. J. Pharmacol., 283 (1995) 99-102.
11. [11] Friedman, P., GB-STAT: Computer Aided Statistics and Graphics, Version 3.0., Dynamic Microsystems Inc., Silver Spring, MD, 1991.
12. [12] Fuller, R.W., Comparison of MPTP and amphetamines as dopaminergic neurotoxins. In J.W. Langston and A. Young (Eds.), Neurotoxins and Neurodegenerative Disease, Ann. NY Acad. Sci., 648 (1992) 87-95.
13. [13] Gaal, J.C., Smith, K.R. and Pearson, C.K., Cellular euthanasia mediated by a nuclear enzyme: a central role for nuclear ADP-ribosylation in cellular metabolism, Trends Biochem. Sci., 12 (1987) 128-129.
14. [14] Johnson, G.S., Benzamide and its derivatives inhibit nicotinamide methylation as well as ADP-ribosylation, Biochem. Int., 2 (1981) 611-617.
15. [15] Lindahl, T., Satoh, M.S., Poirier, G.G. and Klungland, A., Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks, Trends Biochem. Sci., 20 (1995) 405-411.
16. [16] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J., Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193 (1951) 265-275.
17. [17] Marien, M.R., Briley, M. and Colpaert, F., Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice, Eur. J. Pharmacol., 236 (1993) 487-489.
18. [18] Milam, M.K. and Cleaver, E.J., Inhibitors of poly(adenosine diphosphate-ribose) synthesis: effect on other metabolic processes, Science, 223 (1984) 589-591.
19. [19] Miller, M.S., Zobre, C. and Lewis, M., In vitro neuroprotective activity of inhibitors of poly(ADP-ribose) polymerase, Soc. Neurosci. Abstr., 19 (1993) 1656.
20. [20] Miller, D.B. and O'Callaghan, J.P., Environment-, drug-and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57B1/6J mouse, J. Pharmacol. Exp. Ther., 270 (1994) 752-760.
21. [21] Seiden, L.S. and Ricuarte, G.A., Neurotoxicity of methamphetamine and related drugs. In Herbert Y. Meltzer (Ed.), Psychopharmacology: The Third Generation of Progress, Raven Press, New York, 1987, pp. 359-366.
22. [22] Sheng, P., Cerruti, C. and Cadet, J.L., Methamphetamine (METH) causes reactive gliosis in vitro: attenuation by the ADP-ribosylation (ADPR) inhibitor, benzamide, Pharmacol. Lett., 55 (1994) PL51-PL54.
23. [23] Sonsalla, P.K. and Heikkila, R.E., Modulation of methamphetamine-induced neurotoxicity by various pharmacological agents including glutamate receptor antagonists, Eur. J. Pharmacol., 183 (1990) 211-212.
24. [24] Sonsalla, P.K., Nicklas, W. J. and Heikkila, R.E., Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity, Science, 243 (1989) 398-400.
25. [25] Sonsalla, P.K., Giovanni, A., Sieber, B.A., Delle Donne, K. and Manzino, L., Characteristics of dopaminergic neurotoxicity produced by MPTP and methamphetamine. In J.W. Langston and A. Young (Eds.), Neurotoxins and Neurodegenerative Disease, Ann. N. Y. Acad. Sci., 648 (1992) 229-238.
26. [26] Wood, P.L. and Altar, C.A., Dopamine release in vivo from nigrostriatal, mesolimbic and mesocortical neurons: utility of 3-methoxytyramine measurements, Pharmacol. Rev., 40 (1988) 163-187.
27. [27] Zhang, J., Dawson, V.L., Dawson, T.M. and Snyder, S.H., Nitric oxide activation of poly(ADP-ribose)synthetase in neurotoxicity, Science, 263 (1994) 687-689.
28. [28] Zuddas, A., Corsini, G.U., Schinelli, S., Barker, J.L., Kopin, I.J. and di Porzio, U., Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatum, Brain Res., 501 (1989) 11-22.